XML 73 R48.htm IDEA: XBRL DOCUMENT v3.21.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of restatement of balance sheet - USD ($)
Nov. 07, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
As Previously Reported [Member]                
Condensed Balance Sheet Statements, Captions [Line Items]                
Common stock subject to possible redemption $ 112,525,160 $ 123,698,687 $ 120,514,260 $ 120,945,058 $ 121,831,059 $ 123,982,509 $ 124,081,469 $ 123,705,148
Common stock 432 405 435 430 424 403 402 402
Additional paid-in capital 5,020,136 3,699,904 6,884,301 6,453,508 5,567,513 3,416,084 3,317,125 3,693,446
Accumulated deficit (20,567) 1,299,693 (1,884,733) (1,453,933) (567,927) 1,583,517 1,682,483 1,306,153
Total stockholders’ equity (deficit) 5,000,001 5,000,002 5,000,003 5,000,005 5,000,010 5,000,004 5,000,010 5,000,001
Number of shares subject to redemption 11,252,516 12,321,300 12,032,081 12,066,613 12,133,696 12,358,836 12,358,836 12,353,237
Adjustment [Member]                
Condensed Balance Sheet Statements, Captions [Line Items]                
Common stock subject to possible redemption 7,474,840 6,829,335 9,710,295 9,371,001 8,713,900 6,553,480 6,452,799 6,492,214
Common stock (75) (68) (98) (93) (87) (66) (65) (65)
Additional paid-in capital (5,020,136) (3,699,904) (6,884,301) (6,453,508) (5,567,513) (3,416,084) (3,317,125) (3,693,446)
Accumulated deficit (2,454,196) (3,129,363) (2,825,896) (2,917,400) (3,146,300) (3,137,330) (3,135,609) (2,798,703)
Total stockholders’ equity (deficit) (7,474,840) (6,829,335) (9,710,295) (9,371,001) (8,713,900) (6,553,480) (6,452,799) (6,492,214)
Number of shares subject to redemption 747,484 680,252 969,471 934,939 867,856 642,716 642,716 648,315
As Restated [Member]                
Condensed Balance Sheet Statements, Captions [Line Items]                
Common stock subject to possible redemption 120,000,000 130,528,022 130,224,555 130,316,059 130,544,959 130,535,989 130,534,268 130,197,362
Common stock 357 337 337 337 337 337 337 337
Additional paid-in capital
Accumulated deficit (2,475,196) (1,829,670) (4,710,629) (4,371,333) (3,714,227) (1,553,813) (1,453,126) (1,492,550)
Total stockholders’ equity (deficit) (2,474,839) (1,829,333) (4,710,292) (4,370,996) (3,713,890) (1,553,476) (1,452,789) (1,492,513)
Number of shares subject to redemption $ 12,000,000 $ 13,001,552 $ 13,001,552 $ 13,001,552 $ 13,001,552 $ 13,001,552 $ 13,001,552 $ 13,001,552